Cullinan Oncology Inc
General ticker "CGEM" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $720.9M
Cullinan Oncology Inc follows the US Stock Market performance with the rate: 10.4%.
Estimated limits based on current volatility of 4.2%: low 10.73$, high 11.67$
Factors to consider:
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [8.27$, 14.91$]
- 2023-12-31 to 2024-12-30 estimated range: [7.13$, 13.28$]
Short-term CGEM quotes
Long-term CGEM plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $18.94MM | $276.79MM | $0.00MM |
| Operating Expenses | $86.90MM | $132.14MM | $191.09MM |
| Operating Income | $-67.95MM | $144.65MM | $-191.09MM |
| Non-Operating Income | $0.47MM | $6.67MM | $21.87MM |
| R&D Expense | $57.75MM | $91.95MM | $148.16MM |
| Income(Loss) | $-67.48MM | $151.32MM | $-169.22MM |
| Taxes | $0.00MM | $42.12MM | $-16.06MM |
| Profit(Loss) | $-67.48MM | $109.19MM | $-153.16MM |
| Stockholders Equity | $424.97MM | $535.03MM | $453.70MM |
| Assets | $437.19MM | $561.12MM | $484.18MM |
| Operating Cash Flow | $-43.43MM | $-126.66MM | $-134.28MM |
| Capital expenditure | $0.59MM | $1.13MM | $0.21MM |
| Investing Cash Flow | $-333.77MM | $248.97MM | $35.81MM |
| Financing Cash Flow | $268.78MM | $-25.93MM | $40.75MM |
| Earnings Per Share* | $-1.47 | $2.46 | $-3.69 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.